AbbVie (ABBV) YTD return
Updated November 02, 2026 · Data: Yahoo Finance
Price chart
ABBV vs its sector
Underperforming its sector. ABBV is 0.33 points behind the Health Care sector average, which covers 60 ranked S&P 500 stocks.
AbbVie (ABBV) is up +29.40% year-to-date in 2026, ranking #121 of 500 ranked S&P 500 stocks. It closed 2025 at $223.21 and trades at $288.84 as of November 02, 2026. $1,000 invested on December 31, 2025 would be worth $1,294.00 today. That puts it 0.33 points behind the Health Care sector average of +29.73%.
Recent performance
AbbVie (ABBV) has gained 10.57% over the past month, outpacing the S&P 500 by 12.92%, and gained 19.20% over the past three months (ahead of the index by 21.72%). It is trading 2.05% below its 52-week high of $294.89, set on 2026-10-30.
Latest ABBV news
- Brise Pharmaceuticals Announces Global License Agreement with AbbVie to Advance the Next-Generation of Migraine TherapiesPR Newswire · 2026-11-02
- 4 Elite Dividend Stocks That Pay You Passive Income Every Quarter24/7 Wall St. · 2026-11-02
- Goldman Sachs Adjusts Price Target on AbbVie to $313 From $294MT Newswires · 2026-11-02
- 2 Safe S&P 500 Healthcare Dividend Stocks Boomers Can Buy and Hold Forever24/7 Wall St. · 2026-11-02
- The top 5 analyst questions from AbbVie’s Q3 earnings callStockStory · 2026-11-02
Headlines via Yahoo Finance, updated daily.
Where to invest in ABBV
Popular stock brokerages:
We may earn a commission if you sign up through these links, at no extra cost to you.
ABBV YTD return FAQ
What is AbbVie (ABBV)'s YTD return in 2026?
AbbVie (ABBV) is up +29.40% year-to-date in 2026, as of November 02, 2026.
What was AbbVie (ABBV)'s price at the start of 2026?
AbbVie (ABBV) closed at $223.21 on December 31, 2025 and trades at $288.84 as of November 02, 2026.
Where does AbbVie (ABBV) rank by YTD return in 2026?
AbbVie (ABBV) ranks #121 of 500 S&P 500 stocks by YTD return in 2026, as of November 02, 2026.
For informational purposes only, not financial advice.
About · Contact · Privacy Policy · Affiliate Disclosure · Methodology
© 2026 MZX MEDIA LLC. All rights reserved.